Visteon Q3 sales up 6% to $970 million, but cuts adjusted EBITDA outlook
Visteon reported third quarter 2026 net sales of $970 million, up 6% from $917 million a year earlier, and net income attributable to Visteon of $5 million, or $0.19 per diluted share, compared with a loss of $11 million a year earlier. The company raised its full-year sales guidance but lowered its adjusted EBITDA and adjusted free cash flow ranges, citing $77 million of exceptional warranty charges and cost pressures.
Key points
- Q3 sales of $970 million, up from $917 million; net income attributable to Visteon of $5 million ($0.19 diluted EPS) versus a $11 million loss a year earlier
- Q3 adjusted EBITDA of $46 million, including $77 million of exceptional warranty charges, compared with $119 million a year earlier
- Full-year 2026 sales guidance raised to $3.80 to $3.85 billion; adjusted EBITDA guidance lowered to $370 to $410 million and adjusted free cash flow guidance lowered to $90 to $130 million
- Completed a $200 million accelerated share repurchase program in the third quarter
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 7, 2026, 11:17 PM ET, from the text of the filing and its press-release exhibits only.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.